Idenix Loses 1st-Stage of Drug Compounds Patent Case
3/22/2013 5:25:00 PM - Dow Jones Business News
Gilead Says CHMP Expresses Positive Opinion On MAA For Stribild For HIV-1
3/22/2013 9:47:00 AM - RTT News
Gentium Gets Negative Opinion From CHMP; Biogen, Others Get Positive Opinions
3/22/2013 9:18:00 AM - Dow Jones Business News
Gilead And Its Competitors In The Hepatitis C Race
3/21/2013 3:36:00 PM - Seeking Alpha
The Weekend Blitz: Finding Value, Market Behavior, & Diversification Related Plays
3/18/2013 1:02:00 AM - Seeking Alpha
The Stem Cell Revolution Can Jump Start Your Portfolio: Jason Kolbert
3/15/2013 11:20:00 AM - Seeking Alpha
After Hours Most Active for Mar 14, 2013 : BAC, QQQ, RCL, V, JPM, ULTA, GE, C, CSCO, MSFT, GILD, INTC
3/14/2013 4:45:04 PM - NASDAQ.com News
Vertex: The Sun Sets On Incivek, Rises On Its CF Franchise
3/14/2013 11:34:00 AM - Seeking Alpha
Pre-Market Most Active for Mar 14, 2013 : BBRY, VOD, SLCA, BAC, ETFC, GILD, NOK, QQQ, TSM, SD, ERIC, MT
3/14/2013 8:39:56 AM - NASDAQ.com News
Achillion: A Tiny Biopharmaceutical Stock With Tremendous Potential
3/13/2013 9:51:00 PM - Seeking Alpha
Gilead Hits 52-Week High - Analyst Blog
3/13/2013 10:12:09 AM - Zacks.com
Encouraging Data Presented by Gilead - Analyst Blog
3/12/2013 2:31:01 PM - Zacks.com
Gilead Puts Biotech ETFs in Focus - ETF News And Commentary
3/11/2013 11:10:39 AM - Zacks.com
Gilead's Ranexa Reduces Angina Frequency Of Angina Patients With Diabetes
3/10/2013 3:09:00 PM - RTT News
Billionaire Jim Simons' Newest Stock Purchases
3/8/2013 5:36:00 PM - Seeking Alpha
Pfizer Stops Developing Hepatitis C Drug, Cites Strategic Review
3/8/2013 12:12:00 PM - Dow Jones Business News
Amgen And The Biosimilar Threat: Lessons From Affymax
3/8/2013 10:43:00 AM - Seeking Alpha
Seeking Opportunity: Creating A Plan Of Investment Action
3/8/2013 1:27:00 AM - Seeking Alpha
Good News for Gilead's HIV Pipeline - Analyst Blog
3/7/2013 2:40:01 PM - Zacks.com
VIX - Options Volatility And Market Sonar: Wednesday Recap
3/6/2013 5:47:00 PM - Seeking Alpha
Gilead Reveals Full 24-Week Phase 2 Results For HIV Regimen Containing TAF
3/5/2013 12:31:00 PM - RTT News
The Changing Scene Of The AIDS Drug Sector
3/5/2013 11:46:00 AM - Seeking Alpha
The Companies Affected By The Cured HIV Patient
3/5/2013 7:09:00 AM - Seeking Alpha
Gilead Sciences To Present At Cowen Health Care Conference; Webcast At 1:30 PM
3/4/2013 12:30:00 PM - RTT News
Elan Sweetens Shareholder Deal
3/4/2013 8:05:00 AM - Dow Jones Business News
